Ren sanus in corpore sano: the myth of the inexorable decline of renal function with senescence
Danilo Fliser
Hannover Medical School, Hannover, Germany
Correspondence and offprint requests to: Danilo Fliser, MD, Associate Professor of Medicine, Department of Internal Medicine, Hannover Medical School, Carl-Neuberg-Strasse 1, 30265 Hannover, Germany. E-mail: fliser.danilo{at}mh-hannover.de
Keywords: atherosclerosis; elderly; glomerulosclerosis; hypertension; renal function; renovascular resistance
 |
Changing structure of the aging kidney
|
---|
The first notion of an inexorable loss of renal mass with age goes back to uncontrolled observations suggesting that the average kidney weight decreases by up to 40% from young adulthood to senescence [1]. It must be emphasized, however, that in none of these early studies were individuals with comorbid conditions excluded. These findings therefore conflict with observations where no significant decrease in renal mass was found in elderly patients who had suffered traumatic death and in whom renal disease and/or important comorbid conditions were excluded [2]. Moreover, imaging studies investigating changes of renal size and structure showed only a modest decrease until the age of 75 years, whereas thereafter kidney size, calculated volume and parenchymal thickness were clearly lower [3]. Thus, loss of renal mass with aging is moderate, at least until the age of 70 years, and it seems to affect the renal cortex preferentially.
An important factor that correlates with age-associated changes of renal haemodynamics is thought to be glomerulosclerosisas much as 30% of glomeruli were found to be hyalinized or sclerosed in apparently healthy elderly individuals [4]. The results of studies on glomerular number in the human kidney have shown a high degree of variability, however, and hence only minor glomerular obsolescence was found in the elderly who had suffered traumatic death [5, 6]. Kasiske [6] also demonstrated that the severity of systemic atherosclerosis has a major impact on the degree of age-related glomerulosclerosis. Based on these findings, it has been concluded that the presence of glomerulosclerosis is indicative of subclinical renal injury from comorbid conditions affecting renal structure.
 |
Increase of renovascular resistance as a hallmark of renal vascular aging
|
---|
Although several past studies documented a decrease in glomerular filtration rate (GFR) in men as well as in women, most of these studies did not differentiate clearly between the effect of comorbid conditions and the effect of aging per se on renal function [7]. For example, in the seminal study by Davis and Shock [8] virtually all of the examined individuals >70 years of age had generalized atherosclerosis and/or disabling diseases, such as cancer. More recent cross-sectional and prospective studies documented only a modest decrease or even no change of GFR in the healthy elderly [9,10]. In these and other studies, many important factors accelerating the age-related decline of renal function were identified, e.g. hypertension, atherosclerosis (particularly of the lower limbs), smoking and even dietary protein intake (Table 1) [9,1015]. Effective renal plasma flow (ERPF) decreases proportionally more than GFR, i.e. by
10% per decade from young adulthood to the age of 80 years [7,10]. The decrease of ERPF does not concern all renal regions to a similar extent, however. Hollenberg et al. [16] found a significant decrease in the rapid (cortical) component of blood flow while medullary flow was preserved. This finding may, in part, explain the observed increase in the filtration fraction, i.e. the ratio between GFR and ERPF in elderly individuals [7,10,16], since the relative contribution of the juxtamedullary glomeruli with higher filtration fraction increases with age. The decrease in ERPF out of proportion to the change in mean arterial blood pressure with age implies that post-glomerular renovascular resistance (RVR) must be high (Table 2) [10]. Indeed, RVR was found to be significantly increased in normotensive elderly individuals without cardiovascular disease and this increase in RVR is even more pronounced in the elderly with cardiovascular comorbidity, such as hypertension and/or heart failure [10,17].
View this table:
[in this window]
[in a new window]
|
Table 2. Blood pressure, renal haemodynamics and plasma renin activity in young (n = 24) and elderly normotensive (n = 29) subjects, elderly hypertensive patients (n = 25) and elderly patients with compensated mild to moderate heart failure (n = 14)
|
|
It has been proposed that the marked decrease in ERPF and increase in RVR with age results from structural changes of the renal vasculature, i.e. narrowing or even obsolescence of post-glomerular vessels [18]. In addition, renal vasodilation after administration of L-arginine, acetylcholine and dopamine is impaired markedly in the elderly [1921]. Thus, besides structural alterations, changes of vascular function play a pivotal role in the age-related increase of RVR. Vasodilation after administration of acetylcholine or L-arginine is known to be nitric oxide (NO)-dependent, and impaired endothelium-dependent renal vascular relaxation due to reduced NO generation was found in the elderly, particularly in the hypertensive elderly [20]. We have shown recently that accumulation of the endogenous NO synthase inhibitor, asymmetric dimethylarginine, with senescence may play a role in the age-related decrease of renal perfusion [22]. Taken together, the available data permit the conclusion that in the healthy elderly GFR is preserved to some extent, but at the expense of increasing filtration fraction in a vasoconstricted kidney. This condition is accompanied by partial non-responsiveness to vasodilatatory agonists, particularly of the post-glomerular microcirculation.
 |
Renal aging and sodium handling
|
---|
During dietary sodium restriction, the elderly ultimately attain the same minimum urinary sodium excretion, but the rate of decrease of urinary sodium concentration is sluggish and, as a consequence, the net sodium loss is greater than in the young [23]. Both less efficient sodium reabsorption in the proximal tubule and/or reduced activity of the reninangiotensinaldosterone system may contribute to impaired sodium conservation by the senescent kidney (Table 2) [10,24]. In the normotensive elderly, inappropriately low basal and stimulated plasma renin activity are found, i.e. after salt restriction, diuretic treatment or upright posture [24]. Although salt deprivation reveals a salt-losing tendency in the elderly, renal capacity to excrete a salt load is impaired as well. Among other factors, reduced GFR and decreased generation of and/or responsiveness to natriuretic substances, like atrial natriuretic peptide, seem to play a certain role [25]. Thus, the elderly individual is characterized by a relative inability to preserve sodium on the one hand and to excrete an overload of salt on the other. As a result, the range of homeostatic adaptation is decreased. This is of considerable practical importance, since elderly individuals are often threatened by salt and fluid depletion secondary to diarrhoea, treatment with diuretics, etc. On the other hand, the propensity to salt (and fluid) retention may predispose to blood pressure elevation and possibly explain the good response of blood pressure of the elderly to salt restriction and/or diuretic treatment.
 |
The problem of monitoring renal function in the elderly
|
---|
In the elderly, serum creatinine is notoriously unreliable as a precise indicator of GFR due to the fact that the daily production of creatinine is diminished as a result of reduced muscle mass. Consequently, the serum creatinine concentration will underestimate the decline in GFR with age (Table 2) [10,26]. In other words, the normal range of serum creatinine used for the general population is inappropriately high for senescent people. As a consequence, serum creatinine in the upper normal range may already indicate renal disease and impaired renal function in the elderly. A better index of GFR in the elderly may be the serum cystatin C concentration [27,28].
Estimation of the creatinine clearance according to different equations (e.g. CockcroftGault formula) was shown to be unreliable in most studies, especially when very old individuals or individuals with comorbidity were examined [10,29]. This limited accuracy may be relevant when doses of drugs with renal elimination must be calculated. Although in healthy elderly subjects pharmacokinetics of drugs which are excreted via the kidneys is only slightly changed [30], in the sick elderly patient age-related changes in renal function may grossly alter pharmacokinetics of these drugs and their active metabolites. Dose reduction may, therefore, be necessary in order to prevent side effects. Because of the limitations of serum creatinine concentration as a marker of renal function, particularly in the undernourished elderly with reduced muscle mass and spuriously low serum creatinine concentration, a timed endogenous creatinine clearance should be assessed for calculations of drug dosage. However, one must keep in mind that many disabled elderly people are not able to collect a reliable timed urine sample. Regular measurements of plasma drug levels are therefore advised whenever indicated and possible.
 |
Conclusions
|
---|
More detailed knowledge on renal function at advanced age may be of importance on several accounts. Age-related changes may aggravate deterioration of renal function in elderly individuals who happen to have renal diseases. In addition, impaired homeostasis with respect to salt (and fluid) balance has important consequences for the management of the elderly person who is exposed to the twin risks of dehydration and fluid overload. Finally, the kidney is the main route of excretion for many drugs and their active metabolites. Reduction of renal function with age underlies, at least in part, the known predisposition of the elderly to side effects of their medication, such as non-steroidal anti-inflammatory drugs [31].
 |
Acknowledgments
|
---|
Conflict of interest statement. None declared.
 |
References
|
---|
- Tauchi H, Tsuboi K, Okutomi J. Age changes in the human kidney of the different races. Gerontolica 1971; 17: 8797
- Kasiske BL, Umen AJ. The influence of age, sex, race and body habitus on kidney weight in humans. Arch Pathol Lab Med 1986; 110: 5560[ISI][Medline]
- Emamian SA, Nielsen MB, Pederson JF, Ytte L. Kidney dimension at sonography: correlation with age, sex and habitus in 665 adult volunteers. Am J Radiol 1992; 160: 8386[ISI]
- McLahan MSF, Guthrie JC, Anderson CK. Vascular and glomerular changes in the aging kidney. J Pathol 1977; 121: 6577[ISI][Medline]
- Nyengaard JR, Bendtsen TF. Glomerular number and size in relation to age, kidney weight, and body surface in normal man. Anat Rec 1992; 232: 194201[ISI][Medline]
- Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987; 31: 11531159[ISI][Medline]
- Wesson LG. Renal hemodynamics in physiological states. In: Wesson LG, ed. Physiology of the Human Kidney. Grune and Stratton, New York: 1969; 96108
- Davies DF, Shock NW. Age changes in glomerular filtration rate, effective renal plasma flow, and tubular excretory capacity in adult males. J Clin Invest 1950; 29: 496507[ISI]
- Lindeman RD, Tobin JD, Shock NW. Longitudinal studies on the rate of decline in renal function with age. J Am Ger Soc 1985; 33: 278285[ISI][Medline]
- Fliser D, Franek E, Joest M, Block S, Mutschler E, Ritz E. Changes of renal function in the elderly influence of hypertension and cardiac function. Kidney Int 1997; 51: 11961204[ISI][Medline]
- SQ Lew, Bosch JP. Effect of diet on creatinine clearance and excretion in young and elderly healthy subjects and in patients with renal disease. J Am Soc Nephrol 1991; 2: 856865[Abstract]
- Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. Tobacco, hypertension, and vascular disease: risk factors for renal function decline in an older population. Kidney Int 2000; 57: 20722079[CrossRef][ISI][Medline]
- Ribstein J, du Cailar G, Mimran A. Glucose tolerance and age-associated decline in renal function of hypertensive patients. J Hypertens 2001; 19: 22572264[CrossRef][ISI][Medline]
- Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844850[Abstract/Free Full Text]
- Baggio B, Budakovic A, Perissinotto E et al. Atherosclerotic risk factors and renal function in the elderly: the role of hyperfibrinogenaemia and smoking. Results from the Italian Longitudinal Study on Ageing (ILSA). Nephrol Dial Transplant 2004; 20: 114123[CrossRef][ISI][Medline]
- Hollenberg NK, Adams DF, Solomon HS, Rashid A, Abram LA, Merill JP. Senescence and the renal vasculature in normal man. Circ Res 1974; 34: 309316[ISI][Medline]
- Schmieder RE, Schächinger H, Messerli FH. Accelerated decline in renal perfusion with aging in essential hypertension. Hypertension 1994; 23: 351357[Abstract]
- Hoang K, Tan JC, Derby G et al. Determinants of glomerular hypofiltration in aging humans. Kidney Int 2003; 64: 14171424[CrossRef][ISI][Medline]
- Fliser D, Zeier M, Nowack R, Ritz E. Renal functional reserve in healthy elderly people. J Am Soc Nephrol 1993; 3: 13711377[Abstract]
- Higashi Y, Oshima T, Ozono R, Matsuura H, Kajiyama G. Aging and severity of hypertension attenuate endothelium-dependent renal vascular relaxation in humans. Hypertension 1997; 30: 252258[Abstract/Free Full Text]
- Fuiano G, Sund S, Mazza G et al. Renal hemodynamic response to maximal vasodilating stimulus in healthy older subjects. Kidney Int 2001; 59: 10521058[CrossRef][ISI][Medline]
- Kielstein JT, Bode-Böger SM, Frölich JC, Ritz E, Haller H, Fliser D. Asymmetric dimethylarginine, blood pressure, and renal perfusion in elderly subjects. Circulation 2003; 107: 18911895[Abstract/Free Full Text]
- Epstein M, Hollenberg NK. Age as a determinant of renal sodium conservation in normal man. J Lab Clin Med 1976; 87: 411417[ISI][Medline]
- Weidmann P, de Myttenane-Bursztein S, Maxwell M, Delima J. Effect of aging on plasma renin and aldosterone in man. Kidney Int 1975; 8: 325333[ISI][Medline]
- Ohashi M, Fujio M, Nawata H. High plasma concentration of human natriuretic polypeptide in aged men. J Clin Endocrinol Metab 1987; 64: 8185[Abstract]
- Swedko PJ, Clark HD, Paramsothy K, Akbari A. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch Intern Med 2003; 163: 356360[Abstract/Free Full Text]
- Fliser D, Ritz E. Serum cystatin C concentration as a marker of renal dysfunction in the elderly. Am J Kidney Dis 2001; 37: 7983[ISI][Medline]
- Wasen E, Isoaho R, Mattila K, Vahlberg T, Kivela SL, Irjala K. Estimation of glomerular filtration rate in the elderly: a comparison of creatinine-based formulae with serum cystatin C. J Intern Med 2004; 256: 7078[CrossRef][ISI][Medline]
- Drusano GL, Muncie AL, Hoopes JM, Damron DJ, Warren JW. Commonly used methods of estimating creatinine clearance are inadequate for elderly debilitated nursing home patients. J Am Ger Soc 1988; 36: 437441[ISI][Medline]
- Fliser D, Bischof I, Hanses A et al. Renal handling of drugs in the healthy elderly: creatinine clearance underestimates renal function and pharmacokinetics remain virtually unchanged. Eur J Clin Pharmacol 1999; 55: 205211[CrossRef][ISI][Medline]
- Field TS, Gurwitz JH, Glynn RJ et al. The renal effects of non-steroidal anti-inflammatory drugs in older people: findings from the Established Populations for Epidemiologic Studies of the Elderly. J Am Geriatr Soc 1999; 47: 507511[ISI][Medline]